Quick Takeaways
- Octagon Capital Advisors LP filed SCHEDULE 13G/A for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY).
- Disclosed ownership: 5.7%.
- Date of event: 30 Sep 2025.
Octagon Capital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY)
- Filing Manager
- Octagon Capital Advisors LP
- Reporting Manager
- Octagon Capital Advisors LP
- Symbol
- UNCY
- Shares outstanding
- 17,543,860 shares
- Disclosed Ownership
- 1,000,000 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:46:07 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 12 Aug 2025
- Next filing
- 10 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Octagon Capital Advisors LP disclosed 5.7% ownership in Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 12 Aug 2025.
- Current filing was accepted on 14 Nov 2025, 16:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 5.7% | 1,000,000 | 0 | 1,000,000 | /s/ Ting Jia | Managing Member | |
| Octagon Investments Master Fund LP | 3.7% | 650,000 | 0 | 650,000 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Octagon Private Opportunities Fund II LP | 2% | 350,000 | 0 | 350,000 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Ting Jia | 5.7% | 1,000,000 | 0 | 1,000,000 | /s/ Ting Jia | Ting Jia |